Stockreport

Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem Cells

NEURALSTEM  (CUR) 
NASDAQ:AMEX Investor Relations: investor.neuralstem.com
PDF GERMANTOWN, Md., May 16, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today [Read more]